Skip to content
Healing & RepairGrade DWeak, conflicting or negative3 primary sources

KLOW Blend

Also known as KLOW · KPV / GHK-Cu / BPC-157 / TB-500 blend

A four-peptide blend marketed for recovery and gut health. As with all such blends, no study has tested the mixture — only the individual pieces have literature.

Overview

KLOW takes the three peptides in the Glow blend and adds KPV, a short anti-inflammatory fragment of alpha-MSH that has been studied mostly in models of colitis. The pitch is that anti-inflammatory, tissue-repair and matrix-remodelling signals in one injection do more together than separately. That is an assertion, not a finding: there is no combination study, no stability data for four peptides in one vial, and no interaction work.

Research areas

Tissue repairGut inflammationSkin

Community-specified data

Community dosage information

Unverified
Community protocol

KLOW (BPC 10mg|TB-500 10mg|GHK-CU 50mg|KPV 10mg)

Third-party
01Reconstitution solution
2 mL
02Dose
4 mg
03Syringe units
10 units
04Frequency
7x/week
05Cycle length
90 days
06Bacteriostatic water
2 mL
07Bottle size
80 mg
08Bottles needed
5

Source note: Yields 2.5mg GHK-CU / 1mg BPC / 1mg TB4 / 1mg KPV

Track this schedule

Not medical guidance. These third-party figures have not been independently verified, clinically reviewed, or endorsed by DB Peptide. They may be inaccurate or unsafe and should not replace product labelling or advice from a qualified clinician.

Dosing reported in the literature

Every protocol below is reproduced from a published study or approved labelling, with its source named. These are records of what was studied — not recommendations, and not a suggestion that any of them is appropriate for any person.

Protocol as reportedSource
Vendor-published blend protocols, typically a fixed daily subcutaneous dose over 4–8 weeksNot derived from any published study.Supplier marketing material

Trial status

No trials of the combination in any species.

Reported safety signals

  • No safety data exists for the combination.
  • Four unregulated peptides in one vial makes attribution of any adverse effect impossible.
  • Copper-peptide chemistry alongside other peptides raises unaddressed stability questions.
  • The individual component profiles carry whatever evidence exists.

Common questions

Why do blends exist if nothing has been tested?

They simplify a sale. One vial, one price, one protocol. From a research standpoint they are the least informative way to use these compounds, because nothing can be attributed to any single component.

Primary sources

3 citations
  1. 01

    KPV, a tripeptide of alpha-melanocyte stimulating hormone, reduces intestinal inflammation

    Gastroenterology2008

  2. 02

    GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration

    BioMed Research International2015

  3. 03

    Brain-gut axis and pentadecapeptide BPC 157: theoretical and practical implications

    Current Neuropharmacology2016

Medical disclaimer

This page is for informational and research purposes only. Nothing here constitutes medical advice. The compounds discussed are research chemicals. Consult a qualified clinician before starting any protocol.

How this profile was built →